Dr Reddys Laboratories (RDY) EBIT Growth (5y) (2014 - 2026)
Powered by 
Analysis
Dr Reddys Laboratories (RDY) EBIT Growth (5y) (2014 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.56 Bn | 38.91 Bn | 2.15 Bn |
| 2 | Viatris | 19.14 Bn | 18.26 Bn | 1.46 Bn |
| 3 | Dr Reddys Laboratories | 9.89 Bn | 9.71 Bn | 396.53 Mn |
| 4 | Amneal Pharmaceuticals | 5.46 Bn | 5.33 Bn | 334.51 Mn |
| 5 | Bausch Health Companies | 2.33 Bn | 492.63 Mn | 2.10 Bn |
| 6 | Alvotech | 1.51 Bn | 1.36 Bn | 2.56 Mn |
| 7 | Ani Pharmaceuticals | 1.48 Bn | 1.12 Bn | 165.89 Mn |
| 8 | Amphastar Pharmaceuticals | 994.43 Mn | 704.31 Mn | 93.47 Mn |
| 9 | Fennec Pharmaceuticals | 401.07 Mn | 359.82 Mn | 17.15 Mn |
| 10 | RedHill Biopharma | 179.86 Mn | 179.86 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -24.51% |
| Mar 31, 2026 | -30.44% |
| Dec 31, 2025 | 8.98% |
| Sep 30, 2025 | 46.26% |
| Jun 30, 2025 | 12.36% |
| Mar 31, 2025 | 13.12% |
| Dec 31, 2024 | 20.30% |
| Sep 30, 2024 | 36.20% |
| Jun 30, 2024 | 15.84% |
| Mar 31, 2024 | 18.91% |
| Dec 31, 2023 | 21.91% |
| Sep 30, 2023 | 21.10% |
| Jun 30, 2023 | 25.16% |
| Mar 31, 2023 | 26.29% |
| Dec 31, 2022 | 31.09% |
| Sep 30, 2022 | 21.03% |
| Jun 30, 2022 | 22.25% |
| Mar 31, 2022 | 2.33% |
| Dec 31, 2021 | -0.78% |
| Sep 30, 2021 | 19.25% |